Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72,210 ILa | -1.11% | -13.10% | -0.40% |
Sales 2024 * | 2.72B 1T | Sales 2025 * | 3.04B 1,117B | Capitalization | 12.4B 4,549B |
---|---|---|---|---|---|
Net income 2024 * | 449M 165B | Net income 2025 * | 549M 201B | EV / Sales 2024 * | 4.02 x |
Net cash position 2024 * | 1.46B 534B | Net cash position 2025 * | 2.25B 827B | EV / Sales 2025 * | 3.33 x |
P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
21.9
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | -1.11% | ||
1 week | -13.10% | ||
Current month | -13.77% | ||
1 month | -14.34% | ||
3 months | -20.53% | ||
6 months | -2.37% | ||
Current year | -0.40% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 14-04-29 |
Darren Rushworth
PSD | President | 56 | 16-12-31 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 16-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 13-07-31 |
David Kostman
CHM | Chairman | 59 | 00-12-31 |
Dan Falk
BRD | Director/Board Member | 79 | 00-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.58% | 17 M€ | +8.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 72,210 | -1.11% | 149,796 |
24-05-22 | 73,020 | -0.79% | 76,075 |
24-05-21 | 73,600 | +1.70% | 111,799 |
24-05-20 | 72,370 | +1.13% | 170,209 |
24-05-19 | 71,560 | -3.80% | 74,638 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 23, 2024 at 10:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.40% | 12.53B | |
+13.55% | 3,200B | |
+13.86% | 87.43B | |
+8.19% | 79.69B | |
-11.45% | 56.79B | |
+20.68% | 47.14B | |
+28.56% | 46.62B | |
-26.77% | 45.5B | |
+77.11% | 42.31B | |
-5.36% | 25.81B |
- Stock Market
- Equities
- NICE Stock